Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells
Open Access
- 9 February 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (12) , 19354-19364
Abstract
Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cellsKeywords
This publication has 22 references indexed in Scilit:
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular CarcinomaGastroenterology, 2016
- Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective StudyDisease Markers, 2015
- Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer*Molecular & Cellular Proteomics, 2015
- GRP78 Secreted by Colon Cancer Cells Facilitates Cell Proliferation via PI3K/Akt SignalingAsian Pacific Journal of Cancer Prevention, 2014
- Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cellsJournal of Experimental & Clinical Cancer Research, 2012
- Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targetingBiochemical Journal, 2011
- GRP78 Induction in Cancer: Therapeutic and Prognostic ImplicationsCancer Research, 2007
- DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesisOncogene, 2006
- Anti-Angiogenic Effect of Bortezomib in Patients with Multiple MyelomaActa Haematologica, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005